2 results
Approved WMOCompleted
The aim of the present study is to test light treatment through the ear on the biological clock, sleep-wake rhythm, our alertness and functioning.
Approved WMOCompleted
In this study we want to determine the activity and safety of concurrent interruption of the MAPK and PI3K pathways by the EGFR tyrosine kinase inhibitor erlotinb and metformin, combined with gemcitabine in patients with metatastatic pancreatic…